Tower Research Capital »

Bioline Rx shares owned by Tower Research Capital

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $146 39 3.77

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Bioline Rx

Susquehanna International
Citadel Advisors
UBS Group
Rhumbline Advisers
Wells Fargo & Company
Nemes Rush Group
Goss Wealth Management
Simplex Trading
Tower Research Capital
Rockefeller Capital Management
SBI Securities
Danske Bank A/s
Advisor Group Holdings

View all funds holding Bioline Rx